ZA954691B - Antihyperglycaemically active medicaments - Google Patents

Antihyperglycaemically active medicaments

Info

Publication number
ZA954691B
ZA954691B ZA954691A ZA954691A ZA954691B ZA 954691 B ZA954691 B ZA 954691B ZA 954691 A ZA954691 A ZA 954691A ZA 954691 A ZA954691 A ZA 954691A ZA 954691 B ZA954691 B ZA 954691B
Authority
ZA
South Africa
Prior art keywords
antihyperglycaemically
active medicaments
prepn
active
methoxypyrimidine
Prior art date
Application number
ZA954691A
Other languages
English (en)
Inventor
Elbert Kaan
Dieter Ziegler
Reinhard Bruckner
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of ZA954691B publication Critical patent/ZA954691B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA954691A 1994-07-01 1995-06-07 Antihyperglycaemically active medicaments ZA954691B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4423177A DE4423177A1 (de) 1994-07-01 1994-07-01 Antihyperglykämisch wirksame Arzneimittel

Publications (1)

Publication Number Publication Date
ZA954691B true ZA954691B (en) 1996-01-29

Family

ID=6522064

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA954691A ZA954691B (en) 1994-07-01 1995-06-07 Antihyperglycaemically active medicaments

Country Status (23)

Country Link
US (1) US5712283A (cs)
EP (1) EP0689837B1 (cs)
JP (1) JP3841846B2 (cs)
KR (1) KR100366130B1 (cs)
CN (1) CN1092961C (cs)
AT (1) ATE210444T1 (cs)
AU (1) AU691580B2 (cs)
CA (1) CA2152998C (cs)
CZ (1) CZ287563B6 (cs)
DE (2) DE4423177A1 (cs)
DK (1) DK0689837T3 (cs)
DZ (1) DZ1894A1 (cs)
ES (1) ES2167385T3 (cs)
FI (1) FI117374B (cs)
HU (1) HU226946B1 (cs)
IL (1) IL113411A (cs)
NO (1) NO307029B1 (cs)
NZ (1) NZ270990A (cs)
PT (1) PT689837E (cs)
RU (1) RU2145857C1 (cs)
SK (1) SK282227B6 (cs)
UA (1) UA27954C2 (cs)
ZA (1) ZA954691B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977121A (en) * 1995-02-28 1999-11-02 Eli Lilly And Company Use of moxonidine for the treatment of atherosclerosis
PL330637A1 (en) * 1996-06-06 1999-05-24 Lilly Co Eli Agent for and method of treating hypostatic cardiac insufficiency
CA2229123A1 (en) * 1997-02-11 1998-08-11 Mitchell Irvin Steinberg Pharmaceutical agents
DE19722322A1 (de) * 1997-05-28 1998-12-03 Solvay Pharm Gmbh Nephroprotektives Arzneimittel
EP0919234A3 (en) * 1997-10-17 1999-08-25 Eli Lilly And Company Potentiation of pharmaceuticals by moxonidine
US6897019B1 (en) * 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
AU2727400A (en) * 1999-01-29 2000-08-18 Eli Lilly And Company Moxonidine salts
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
AU2003257418A1 (en) * 2002-06-19 2004-01-06 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
BRPI0415198A (pt) * 2003-10-10 2006-12-05 Solvay Pharm Gmbh composição farmacêutica compreendendo um agonista seletivo do receptor da imidazolina i1 e um bloqueador do receptor da angiotensina ii
RU2542462C2 (ru) * 2013-06-28 2015-02-20 Андрей Владиславович Струтынский Способ коррекции кризового течения гипертонической болезни и абдоминального ожирения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2849537C2 (de) * 1978-11-15 1983-03-17 Beiersdorf Ag, 2000 Hamburg Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
FR2669927B1 (fr) * 1990-11-29 1994-04-08 Adir Cie Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
AU691580B2 (en) 1998-05-21
DK0689837T3 (da) 2002-03-11
FI953256A (fi) 1996-01-02
KR100366130B1 (ko) 2003-03-26
SK74995A3 (en) 1996-05-08
HUT72599A (en) 1996-05-28
UA27954C2 (uk) 2000-10-16
DE4423177A1 (de) 1996-01-04
EP0689837A3 (de) 1996-06-05
IL113411A0 (en) 1995-07-31
KR960003729A (ko) 1996-02-23
HU9501900D0 (en) 1995-08-28
JPH0840906A (ja) 1996-02-13
PT689837E (pt) 2002-04-29
NO952624L (no) 1996-01-02
NO307029B1 (no) 2000-01-31
RU2145857C1 (ru) 2000-02-27
ATE210444T1 (de) 2001-12-15
NO952624D0 (no) 1995-06-30
FI117374B (fi) 2006-09-29
JP3841846B2 (ja) 2006-11-08
FI953256A0 (fi) 1995-06-30
CN1092961C (zh) 2002-10-23
CZ287563B6 (en) 2000-12-13
CA2152998C (en) 2002-09-03
DE59509928D1 (de) 2002-01-24
CZ139395A3 (en) 1996-01-17
US5712283A (en) 1998-01-27
SK282227B6 (sk) 2001-12-03
AU1775795A (en) 1996-01-18
IL113411A (en) 1999-07-14
ES2167385T3 (es) 2002-05-16
HU226946B1 (en) 2010-03-29
EP0689837B1 (de) 2001-12-12
NZ270990A (en) 1997-06-24
CA2152998A1 (en) 1996-01-02
CN1122224A (zh) 1996-05-15
EP0689837A2 (de) 1996-01-03
DZ1894A1 (fr) 2002-02-17

Similar Documents

Publication Publication Date Title
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
GR3004482T3 (cs)
ZA954691B (en) Antihyperglycaemically active medicaments
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
EP0369887A3 (fr) Utilisation de trifluorométhylphényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles anxio-dépressifs
EP0330052A3 (de) Verwendung von Benzimidazolen zur Herstellung eines Arzneimittels mit antiischämischen Wirkungen am Herzen und dessen Kombinationen mit Beta-Blockern oder Bradycardica
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
EP0471388A3 (de) Mittel zur Behandlung der Herzinsuffizienz
GR861646B (en) 4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidino-5-carbonic acid -(n-triphthoro - methyl-phenyl)-amides for antithrombotic protection and treatment use and preparation of antithrombotically active medicines
WO1987003590A1 (en) Medicament for the treatment of diseases of the liver
DE69106276D1 (de) Säureadditionssalze einer optisch aktiven Alaninanilidverbindung und diese enthaltende, pharmazeutische Zusammensetzungen.
JPS6434920A (en) Therapy for mycobacterium abium intracellular complex infection
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
MX9102181A (es) Iminobenzodiazepina para el tratamiento de desordenes del sueno
IL100889A0 (en) Substituted benzofuranylpiperidine as a nootropic agent
PT82535B (en) Pharmacologically active propionylanilides